Orally‐administrated mitochondria attenuate pulmonary hypertension with the aid of erythrocytes as carriers
Main Authors: | Rui Xiao, Jie Liu, Shengquan Luo, Zhe Yu, Jiwei Zhang, Yankai Lv, Jiansha Li, Matthieu Ruiz, Jocelyn Dupuis, Qinghua Hu, Liping Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.1033 |
Similar Items
-
Extracellular vesicles in venous thromboembolism and pulmonary hypertension
by: Jiwei Zhang, et al.
Published: (2023-11-01) -
Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium–Sensing Receptor
by: Rui Xiao, et al.
Published: (2017-04-01) -
How single-cell techniques help us look into lung cancer heterogeneity and immunotherapy
by: Pu Liao, et al.
Published: (2023-08-01) -
Erythrocytes as Carriers of Therapeutic Enzymes
by: Bridget E. Bax
Published: (2020-05-01) -
Erythrocyte zinc protoporphyrin in beta-thalassaemia carriers
by: George, Elizabeth, et al.
Published: (2008)